Institutional Ownership Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN). We have compiled data on the 130 institutions that hold shares in the stock, with a total of 35.9 Million shares, which have been reported (via 13F filing form) to have a value of $384 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
3,787,347
shares
|
$40.3 Million
0.77% of portfolio
|
Q3 2024
Added 6.47%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
3,735,741
shares
|
$39.7 Million
0.09% of portfolio
|
Q3 2024
Added 13.2%
|
|
|
Menora Mivtachim Holdings Ltd.
|
Nov 14, 2024 Q3 2024 |
2,303,031
shares
|
$24.5 Million
0.19% of portfolio
|
Q3 2023
Reduced 8.96%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,193,950
shares
|
$23.3 Million
0.0% of portfolio
|
Q2 2024
Added 27.79%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
2,181,464
shares
|
$23.2 Million
0.0% of portfolio
|
Q3 2024
Added 18.64%
|
|
|
Cowen And Company, LLC
|
Nov 12, 2024 Q3 2024 |
1,796,589
shares
|
$19.1 Million
0.59% of portfolio
|
Q3 2024
Reduced 14.43%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,550,000
shares
|
$16.5 Million
1.38% of portfolio
|
Q3 2024
Reduced 6.06%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2024 Q3 2024 |
1,506,646
shares
|
$16 Million
0.05% of portfolio
|
Q3 2024
Reduced 38.49%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
1,499,201
shares
|
$16 Million
0.01% of portfolio
|
Q3 2024
Added 29.14%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
1,341,072
shares
|
$14.3 Million
0.0% of portfolio
|
Q3 2024
Added 1.6%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,200,000
shares
|
$12.8 Million
0.02% of portfolio
|
Q4 2023
Added 13.21%
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
965,000
shares
|
$10.3 Million
0.09% of portfolio
|
Q2 2024
Added 14.88%
|
|
|
Silverarc Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
901,129
shares
|
$9.59 Million
2.85% of portfolio
|
Q3 2024
Reduced 18.23%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
769,583
shares
|
$8.19 Million
0.0% of portfolio
|
Q3 2024
Added 5.9%
|
|
|
Great Point Partners LLC
Greenwich, CT |
Nov 13, 2024 Q3 2024 |
758,786
shares
|
$8.07 Million
4.46% of portfolio
|
Q3 2024
Reduced 73.89%
|
|
|
Migdal Insurance & Financial Holdings Ltd.
|
Nov 04, 2024 Q3 2024 |
686,472
shares
|
$7.3 Million
0.14% of portfolio
|
Q1 2024
Added 5.89%
|
|
|
Wildcat Capital Management, LLC
|
Nov 08, 2024 Q3 2024 |
495,606
shares
|
$5.27 Million
3.08% of portfolio
|
Q2 2023
New holding
|
|
|
Harel Insurance Investments & Financial Services Ltd.
|
Oct 15, 2024 Q3 2024 |
463,267
shares
|
$4.93 Million
0.1% of portfolio
|
Q3 2024
Reduced 0.06%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2024 Q3 2024 |
458,915
shares
|
$4.88 Million
1.5% of portfolio
|
Q3 2024
Reduced 2.15%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
455,637
shares
|
$4.85 Million
0.0% of portfolio
|
Q3 2024
Added 8.13%
|
|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2024 Q3 2024 |
404,100
shares
|
$4.3 Million
0.94% of portfolio
|
Q3 2024
Reduced 1.92%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
400,000
shares
|
$4.26 Million
0.39% of portfolio
|
Q3 2024
New holding
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
347,541
shares
|
$3.7 Million
0.62% of portfolio
|
Q3 2024
Added 26.62%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
315,957
shares
|
$3.36 Million
0.0% of portfolio
|
Q3 2024
Added 19.86%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
305,642
shares
|
$3.25 Million
0.04% of portfolio
|
Q3 2024
Added 0.63%
|